Security key
90466Y103
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 14,441,576
- Total 13F value
- $19,929,234
- Share change
- +4,849,086
- SEC-reported price per share
- $1.38
- Number of holders
- 21
- Value change
- +$6,691,650
- Number of buys
- 14
- Number of sells
- 1
- Shares outstanding
- 18,578,488
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
21
Top holders
10
UNCY full security history
Ownership snapshot
Full 13F holder table
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $3,011,516
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $3.01M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value
Top 5
RA CAPITAL MANAGEMENT, L.P.
$3.01M
Vivo Capital, LLC
$3.01M
Nantahala Capital Management, LLC
$2.98M
BVF INC/IL
$1.84M
GEODE CAPITAL MANAGEMENT, LLC
$146.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$3,011,516
3,470,688 shares
|
— | 31 Dec 2023 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$3,011,051
3,470,152 shares
|
— | 31 Dec 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$2,983,309
3,438,181 shares
|
— | 31 Dec 2023 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$1,837,909
2,118,139 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$146,755
169,132 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$99,835
115,057 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
14,441,576
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
21
Q1 2024 holders
21
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|